Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
$90.26
-0.38%today
MKT CAP
$12.2B
-5.3% · 1Y
Earnings History
+14.9%
+51.1%
+11.0%
+21.7%
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Analyst Targets
Current price
$90.26
Low
$92.00
Analyst Mean
$111.50
High
$123.00
12 analystsBuy
Full Financials
Trailing P/E23.0x
Forward P/E18.2x
EV/EBITDA12.6x
Price/Sales-
Dividend Yield-
Revenue Growth YoY+25.7%
Earnings Growth YoY+437.0%
Revenue Growth QoQ-8.1%
5y Revenue CAGR+42.2%
5y Earnings CAGR+41.4%
Gross Margin68.1%
Operating Margin24.4%
Net Margin18.3%
ROE12.3%
Debt / Equity2.61x
Free Cash Flow$328M
Insider Ownership0.7%
Institutional Ownership102.4%
Short % of Float2.95%
Days to Cover3.1d
1 Week-0.9%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| HULLER KELLY GRACE | General Counsel | Sale | 20,000 | $94.50 | $1.89M | 2026-02-25 |
| HULLER KELLY GRACE | General Counsel | Conversion | 20,000 | $43.58 | $0.87M | 2026-02-25 |
| HULLER KELLY GRACE | General Counsel | Sale | 10,000 | $87.67 | $0.88M | 2026-02-12 |
| HULLER KELLY GRACE | General Counsel | Conversion | 10,000 | $45.64 | $0.46M | 2026-02-12 |
| NORWALK LESLIE V | Director | Sale | 2,000 | $101.10 | $0.20M | 2026-01-08 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Vanguard Group Inc | institution | 9.32% | $0.82B | -0.53% | 2025-12-31 |
| Blackrock Inc. | institution | 9.08% | $0.80B | -2.37% | 2025-12-31 |
| Janus Henderson Group PLC | institution | 6.44% | $0.57B | -3.41% | 2025-12-31 |
| Invesco Ltd. | institution | 3.43% | $0.30B | +1235.23% | 2025-12-31 |
| iShares Trust-iShares Core S&P Mid-Cap ETF | fund | 3.26% | $0.29B | +2.57% | 2026-03-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 3.13% | $0.28B | -0.07% | 2025-12-31 |
| State Street Corporation | institution | 3.06% | $0.27B | +0.06% | 2025-12-31 |
| Bank of Montreal /CAN/ | institution | 2.98% | $0.26B | +15317.09% | 2025-12-31 |
| JPMORGAN CHASE & CO | institution | 2.74% | $0.24B | -57.92% | 2025-12-31 |
| Sculptor Capital LP | institution | 2.65% | $0.23B | -14.29% | 2025-12-31 |
| Madison Avenue Partners, LP | institution | 2.32% | $0.20B | +3.01% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | fund | 2.25% | $0.20B | -4.65% | 2025-12-31 |
| Citadel Advisors Llc | institution | 2.24% | $0.20B | +2165.44% | 2025-12-31 |
| JANUS INVESTMENT FUND-Janus Henderson Enterprise Fund | fund | 1.95% | $0.17B | +0.00% | 2026-03-31 |
| J.P. Morgan Fleming Mutual Fd. Group, Inc.-JPMorgan Mid Cap Value Fd. | fund | 1.55% | $0.14B | -17.07% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | fund | 1.27% | $0.11B | -3.96% | 2025-12-31 |
| AIM Sector Fd.s -INVESCO VALUE OPPORTUNITIES Fd. | fund | 1.24% | $0.11B | +0.00% | 2026-01-31 |
| AIM Sector Funds (Invesco Sector Funds)-INVESCO SMALL CAP VALUE FUND | fund | 1.23% | $0.11B | -24.11% | 2026-01-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | fund | 1.06% | $0.09B | -0.38% | 2025-12-31 |
| JANUS INVESTMENT FUND-Janus Henderson Triton Fund | fund | 0.97% | $0.09B | -2.40% | 2026-03-31 |
| Ticker | Cap | Score | P/E | Fwd P/E | EV/EBITDA | ROE | Gross | D/E | Div |
|---|---|---|---|---|---|---|---|---|---|
| PEN | $12.8B | 60 | 74.8 | 51.0 | 58.0 | 12.7% | 67% | 14.67 | 0.00% |
| SNN | $12.9B | 66 | 21.0 | 14.4 | 21.2 | 11.8% | 68% | 62.90 | 260.00% |
| PODD | $10.6B | 74 | 37.5 | 19.9 | 19.7 | 23.0% | 71% | 77.98 | 0.00% |
| MASI | $9.3B | 31 | 46.6 | 27.0 | - | - | - | - | 0.00% |
| ZBH | $16.1B | 76 | 21.6 | 9.3 | 9.0 | 6.1% | 70% | 59.83 | 115.00% |
| GKOS | $8.0B | 5 | - | 279.0 | - | - | - | - | 0.00% |
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for GMED.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.